Two 340B hospitals urged a federal district court to block drugmaker Johnson & Johnson (J&J) from conducting “unlawfully authorized” audits [...] …
Category: Judicial
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Just days after a federal court in Mississippi denied Novartis’ attempt to block the state’s 340B contract pharmacy access law, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health System Urges Federal Appeals Court to Revive 340B Overcharge Lawsuit Against Major Drugmakers
A California health system has urged a federal appeals court to reverse a lower court’s decision to dismiss its lawsuit [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Pharmaceutical giant AbbVie yesterday became the first drugmaker to file suit against Missouri’s new law prohibiting 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this summer, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The West Virginia attorney general and multiple hospital groups recently urged a federal district judge to deny Novartis’ motion to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A group of Texas hospitals urged a federal court last week to grant their request for a summary judgement—or at [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The 340B program faces unprecedented challenges despite a series of states enacting 340B contract pharmacy access laws, the leader of [...] …
